Form 8-K Ocugen, Inc. For: May 14

Go back to Form 8-K Ocugen, Inc. For: May 14

Ocugen appoints new acting chief medical officer

May 14, 2026 4:41 PM EDT

Ocugen Inc. (NASDAQ: OCGN) announced leadership changes in its medical department. Huma Qamar, M.D., MPH, CMI, separated from the company as Chief Medical Officer effective May 8, 2026.

The company appointed Mohamed Genead, M.D., M.Sc., as Acting/Interim Chief Medical... More